173 related articles for article (PubMed ID: 27493974)
41. Dysfunctional T regulatory cells in multiple myeloma.
Prabhala RH; Neri P; Bae JE; Tassone P; Shammas MA; Allam CK; Daley JF; Chauhan D; Blanchard E; Thatte HS; Anderson KC; Munshi NC
Blood; 2006 Jan; 107(1):301-4. PubMed ID: 16150935
[TBL] [Abstract][Full Text] [Related]
42. Circulating Adiponectin Levels Differ Between Patients with Multiple Myeloma and its Precursor Disease.
Hofmann JN; Mailankody S; Korde N; Wang Y; Tageja N; Costello R; Zingone A; Hultcrantz M; Pollak MN; Purdue MP; Landgren O
Obesity (Silver Spring); 2017 Aug; 25(8):1317-1320. PubMed ID: 28602036
[TBL] [Abstract][Full Text] [Related]
43. Advanced flowcytometric analysis of regulatory T cells: CD127 downregulation early post stem cell transplantation and altered Treg/CD3(+)CD4(+)-ratio in severe GvHD or relapse.
Bremm M; Huenecke S; Lehrnbecher T; Ponstingl E; Mueller R; Heinze A; Bug G; Quaiser A; Kapinsky M; Brehm C; Bader P; Schneider G; Klingebiel T; Koehl U
J Immunol Methods; 2011 Oct; 373(1-2):36-44. PubMed ID: 21839739
[TBL] [Abstract][Full Text] [Related]
44. The predictive power of serum kappa/lambda ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma.
Bergón E; Miravalles E; Bergón E; Miranda I; Bergón M
Clin Chem Lab Med; 2005; 43(1):32-7. PubMed ID: 15653439
[TBL] [Abstract][Full Text] [Related]
45. Next generation flow for minimally-invasive blood characterization of MGUS and multiple myeloma at diagnosis based on circulating tumor plasma cells (CTPC).
Sanoja-Flores L; Flores-Montero J; Garcés JJ; Paiva B; Puig N; García-Mateo A; García-Sánchez O; Corral-Mateos A; Burgos L; Blanco E; Hernández-Martín J; Pontes R; Díez-Campelo M; Millacoy P; Rodríguez-Otero P; Prosper F; Merino J; Vidriales MB; García-Sanz R; Romero A; Palomera L; Ríos-Tamayo R; Pérez-Andrés M; Blanco JF; González M; van Dongen JJM; Durie B; Mateos MV; San-Miguel J; Orfao A;
Blood Cancer J; 2018 Nov; 8(12):117. PubMed ID: 30455467
[TBL] [Abstract][Full Text] [Related]
46. Monoclonal gammopathy and smoldering multiple myeloma: diagnosis, staging, prognosis, management.
Hillengass J; Moehler T; Hundemer M
Recent Results Cancer Res; 2011; 183():113-31. PubMed ID: 21509683
[TBL] [Abstract][Full Text] [Related]
47. Aberrant GITR expression on different T cell subsets and the regulation by glucocorticoid in systemic lupus erythematosus.
Sun J; Yu N; Li X; Wang L; Pan Y; Li X; Tao J; Chen Z; Wang G
Int J Rheum Dis; 2016 Feb; 19(2):199-204. PubMed ID: 25293713
[TBL] [Abstract][Full Text] [Related]
48. [The OKT4/OKT8 ratio in benign monoclonal gammopathies].
La Rosa L; Mattoni C; La Rosa M
Minerva Med; 1988 Dec; 79(12):1049-50. PubMed ID: 2974933
[TBL] [Abstract][Full Text] [Related]
49. Differing coagulation profiles of patients with monoclonal gammopathy of undetermined significance and multiple myeloma.
Crowley MP; Quinn S; Coleman E; Eustace JA; Gilligan OM; O'Shea SI
J Thromb Thrombolysis; 2015 Feb; 39(2):245-9. PubMed ID: 25271000
[TBL] [Abstract][Full Text] [Related]
50. A contribution to examination of propidium iodide and annexin V plasma cells indices in multiple myeloma.
Scudla V; Ordeltova M; Bacovsky J; Vytrasova M; Sumna E; Martinek A; Horak P
Neoplasma; 2003; 50(5):363-71. PubMed ID: 14628090
[TBL] [Abstract][Full Text] [Related]
51. Treg and Oligoclonal Expansion of Terminal Effector CD8
Joshua DE; Vuckovic S; Favaloro J; Lau KHA; Yang S; Bryant CE; Gibson J; Ho PJ
Front Immunol; 2021; 12():620596. PubMed ID: 33708212
[TBL] [Abstract][Full Text] [Related]
52. Increase in the suppressor-inducer T cell subset in multiple myeloma and monoclonal gammopathy of undetermined significance.
Shapira R; Froom P; Kinarty A; Aghai E; Lahat N
Br J Haematol; 1989 Feb; 71(2):223-5. PubMed ID: 2522313
[TBL] [Abstract][Full Text] [Related]
53. Increased activated regulatory T cell subsets and aging Treg-like cells in multiple myeloma and monoclonal gammopathy of undetermined significance: a case control study.
Wang JN; Cao XX; Zhao AL; Cai H; Wang X; Li J
Cancer Cell Int; 2018; 18():187. PubMed ID: 30479566
[TBL] [Abstract][Full Text] [Related]
54. Genomewide profiling of copy-number alteration in monoclonal gammopathy of undetermined significance.
Mikulasova A; Smetana J; Wayhelova M; Janyskova H; Sandecka V; Kufova Z; Almasi M; Jarkovsky J; Gregora E; Kessler P; Wrobel M; Walker BA; Wardell CP; Morgan GJ; Hajek R; Kuglik P
Eur J Haematol; 2016 Dec; 97(6):568-575. PubMed ID: 27157252
[TBL] [Abstract][Full Text] [Related]
55. The t(14;20) is a poor prognostic factor in myeloma but is associated with long-term stable disease in monoclonal gammopathies of undetermined significance.
Ross FM; Chiecchio L; Dagrada G; Protheroe RK; Stockley DM; Harrison CJ; Cross NC; Szubert AJ; Drayson MT; Morgan GJ;
Haematologica; 2010 Jul; 95(7):1221-5. PubMed ID: 20410185
[TBL] [Abstract][Full Text] [Related]
56. Host-related immunodeficiency in the development of multiple myeloma.
Dosani T; Mailankody S; Korde N; Manasanch E; Bhutani M; Tageja N; Roschewski M; Kwok M; Kazandjian D; Costello R; Burton D; Zhang Y; Liewehr D; Steinberg SM; Maric I; Landgren O
Leuk Lymphoma; 2018 May; 59(5):1127-1132. PubMed ID: 28792255
[TBL] [Abstract][Full Text] [Related]
57. Natural killer cell frequency and function in patients with monoclonal gammopathies.
Famularo G; D'Ambrosio A; Quintieri F; Di Giovanni S; Parzanese I; Pizzuto F; Giacomelli R; Pugliese O; Tonietti G
J Clin Lab Immunol; 1992; 37(3):99-109. PubMed ID: 1285130
[TBL] [Abstract][Full Text] [Related]
58. A case series of autoimmune diseases accompanied by incidentally diagnosed monoclonal gammopathy: is there a link between the two diseases?
Cho SY; Yang HS; Jeon YL; You E; Lee HJ; Yoon HJ; Park TS
Int J Rheum Dis; 2014 Jul; 17(6):635-9. PubMed ID: 24460798
[TBL] [Abstract][Full Text] [Related]
59. The imbalance between Tregs, Th17 cells and inflammatory cytokines among renal transplant recipients.
Ma L; Zhang H; Hu K; Lv G; Fu Y; Ayana DA; Zhao P; Jiang Y
BMC Immunol; 2015 Sep; 16():56. PubMed ID: 26400627
[TBL] [Abstract][Full Text] [Related]
60. Imbalance between circulating CD4+ regulatory T and conventional T lymphocytes in patients with HBV-related acute-on-chronic liver failure.
Dong X; Gong Y; Zeng H; Hao Y; Wang X; Hou J; Wang J; Li J; Zhu Y; Liu H; Han J; Zhou H; Shen L; Gao T; Zhou T; Yang S; Li S; Chen Y; Meng Q; Li H
Liver Int; 2013 Nov; 33(10):1517-26. PubMed ID: 23869954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
